6 JANUARY 2023

PHARMANIAGA EXPAND DISTRIBUTION CAPACITY IN NORTHERN REGION

6 JANUARI 2023

PHARMANIAGA TINGKATKAN KAPASITI LOGISTIK DAN EDARAN DI WILAYAH UTARA

13 DECEMBER 2022

PHARMANIAGA AND BIONET SIGN RESEARCH COLLABORATION AGREEMENT FOR CHILDREN’S HEXAVALENT VACCINE

13 DISEMBER 2022

PHARMANIAGA DAN BIONET TANDATANGAN PERJANJIAN KOLABORASI PENYELIDIKAN BAGI VAKSIN HEXAVALENT KANAK-KANAK

10 DECEMBER 2022

PHARMANIAGA STRENGTHENS ESG AND SUSTAINABILITY INITIATIVES THROUGH DECARBONISATION PROGRAMME

10 DISEMBER 2022

PHARMANIAGA KUKUHKAN BUDAYA ESG DAN KELESTARIAN MENERUSI PROGRAM DEKARBONISASI

24 NOVEMBER 2022

INTERNATIONAL OPERATIONS AND PRIVATE SECTOR CONTINUE TO BE THE GROWTH DRIVERS FOR PHARMANIAGA

24 NOVEMBER 2022

SEGMEN PERNIAGAAN ANTARABANGSA DAN SEKTOR SWASTA MEMACU PERTUMBUHAN UTAMA PHARMANIAGA

11 NOVEMBER 2022

PHARMANIAGA ENSURES SUFFICIENT SUPPLY OF SINOVAC COVID-19 VACCINE FOR CHILDREN, ADOLESCENTS AND BOOSTER FOR ADULTS AT PRIVATE HOSPITALS AND CLINICS

11 NOVEMBER 2022

PHARMANIAGA PASTIKAN BEKALAN VAKSIN COVID-19 SINOVAC UNTUK KANAK-KANAK DAN REMAJA, SERTA DOS PENGGALAK UNTUK DEWASA MENCUKUPI DI HOSPITAL DAN KLINIK SWASTA

31 OCTOBER 2022

PHARMANIAGA TEMBUSI PASARAN PENJAGAAN KESIHATAN DI PLATFORM E-DAGANG TERBESAR DI CHINA

31 OCTOBER 2022

PHARMANIAGA PENETRATES CHINA HEALTHCARE MARKET, PARTNERS WITH CHINA’S LARGEST E-COMMERCE PLATFORM (MANDARIN VERSION)

31 OCTOBER 2022

PHARMANIAGA PENETRATES CHINA HEALTHCARE MARKET, PARTNERS WITH CHINA’S LARGEST E-COMMERCE PLATFORM